NPPB and heart failure: Given the value of BNP in terms of identifying both frailty and risk of mortality, the addition of this relatively low cost and easy to acquire biomarker to the RiskOP mortality model adds a modest effect to the accuracy of a comprehensive risk prediction, although its value is greater for those without a prior diagnosis of heart failure.